Drug Shortage Report for DESFERAL 500MG
Report ID | 232790 |
Drug Identification Number | 01981242 |
Brand name | DESFERAL 500MG |
Common or Proper name | DESFERAL 500MG 1 X 10 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEFEROXAMINE MESYLATE |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR |
Packaging size | 1 X 10 |
ATC code | V03AC |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-07-15 |
Actual start date | |
Estimated end date | 2024-09-15 |
Actual end date | 2024-09-05 |
Shortage status | Resolved |
Updated date | 2024-09-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-09-06 | English | Compare |
v11 | 2024-09-05 | French | Compare |
v10 | 2024-09-05 | English | Compare |
v9 | 2024-09-05 | French | Compare |
v8 | 2024-09-05 | English | Compare |
v7 | 2024-09-05 | French | Compare |
v6 | 2024-09-05 | English | Compare |
v5 | 2024-07-16 | English | Compare |
v4 | 2024-07-12 | French | Compare |
v3 | 2024-07-12 | English | Compare |
v2 | 2024-07-12 | French | Compare |
v1 | 2024-07-12 | English | Compare |
Showing 1 to 12 of 12